Robert C. Walker - Publications

1989 California Institute of Technology, Pasadena, CA 

8/17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Izadi F, Sharpe BP, Breininger SP, Secrier M, Gibson J, Walker RC, Rahman S, Devonshire G, Lloyd MA, Walters ZS, Fitzgerald RC, Rose-Zerilli MJJ, Underwood TJ, On Behalf Of Occams. Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancers. 13. PMID 34298611 DOI: 10.3390/cancers13143394  1
2021 Ococks E, Sharma S, Tian Ng AW, Aleshin A, Fitzgerald RC, Smyth E, Fitzgerald RC, Edwards PAW, Grehan N, Nutzinger B, Fidziukiewicz E, Redmond AM, Northrop A, Abbas S, ... ... Walker RC, et al. Serial ctDNA detection using a personalized, tumor-informed assay in esophageal adenocarcinoma patients following resection. Gastroenterology. PMID 34284036 DOI: 10.1053/j.gastro.2021.07.011  1
2021 Rahman SA, Walker RC, Maynard N, Trudgill N, Crosby T, Cromwell DA, Underwood TJ. The AUGIS Survival Predictor: Prediction of Long-term and Conditional Survival after Esophagectomy Using Random Survival Forests. Annals of Surgery. PMID 33630434 DOI: 10.1097/SLA.0000000000004794  1
2020 Pucher PH, Rahman SA, Walker RC, Grace BL, Bateman A, Iveson T, Jackson A, Rees C, Byrne JP, Kelly JJ, Noble F, Underwood TJ. Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 32694054 DOI: 10.1016/j.ejso.2020.06.038  1
2020 Rahman SA, Walker RC, Lloyd MA, Grace BL, van Boxel GI, Kingma BF, Ruurda JP, van Hillegersberg R, Harris S, Parsons S, Mercer S, Griffiths EA, O'Neill JR, Turkington R, Fitzgerald RC, et al. Machine learning to predict early recurrence after oesophageal cancer surgery. The British Journal of Surgery. PMID 31997313 DOI: 10.1002/bjs.11461  1
2010 Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, Walker RC, Hirsch V, Strebel K. Stably expressed APOBEC3F has negligible antiviral activity. Journal of Virology. 84: 11067-75. PMID 20702622 DOI: 10.1128/Jvi.01249-10  1
2010 Walker RC, Khan MA, Kao S, Goila-Gaur R, Miyagi E, Strebel K. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif. Journal of Virology. 84: 5201-11. PMID 20219919 DOI: 10.1128/Jvi.02318-09  1
2009 Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC, Strebel K. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization. Retrovirology. 6: 99. PMID 19886996 DOI: 10.1186/1742-4690-6-99  1
Low-probability matches
2021 . Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 33451919 DOI: 10.1016/j.ejso.2020.12.006  0.01
2021 Harrington J, Lloyd M, Mabrouk N, Walker R, Grace B, Underwood T. P13: CHARACTERISATION OF THE TUMOUR MICROENVIRONMENT IN MESENCHYMAL GASTRIC TUMOURS USING SINGLE-CELL RNA SEQUENCING British Journal of Surgery. 108. DOI: 10.1093/BJS/ZNAB117.098  0.01
2021 Lloyd M, Izadi F, Rahman S, Walker R, Hayden A, Harrington J, Grace B, Horne J, Machado M, Underwood T. O29: PREDICTING RESPONSE TO NEOADJUVANT THERAPY IN OESOPHAGEAL ADENOCARCINOMA PRE-TREATMENT BIOPSIES British Journal of Surgery. 108. DOI: 10.1093/BJS/ZNAB117.029  0.01
2020 Walker R, Harrington J, Grace B, Sharpe B, Breininger S, Izadi F, Kelly J, Byrne J, Noble F, Rose-Zerilli M, Underwood T. 514 CANCER CELLS PERSIST AFTER COMPLETE PATHOLOGICAL RESPONSE IN ESOPHAGEAL ADENOCARCINOMA Diseases of the Esophagus. 33. DOI: 10.1093/DOTE/DOAA087.136  0.01
2020 Izadi F, Devonshire G, Walker R, Lloyd M, Gibson J, Secrier M, Fitzgerald R, Rose-Zerilli M, Underwood T. 474 Genomic Analysis Of Response To Neoadjuvant Chemotherapy In Esophageal Adenocarcinoma Diseases of the Esophagus. 33. DOI: 10.1093/Dote/Doaa087.122  0.01
2019 Frankell AM, Jammula S, Li X, Contino G, Killcoyne S, Abbas S, Perner J, Bower L, Devonshire G, Ococks E, Grehan N, Mok J, O'Donovan M, MacRae S, Eldridge MD, et al. The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nature Genetics. PMID 30718927 DOI: 10.1038/S41588-018-0331-5  0.01
2018 Walker RC, Underwood TJ. Molecular pathways in the development and treatment of oesophageal cancer. Best Practice & Research. Clinical Gastroenterology. 9-15. PMID 30551862 DOI: 10.1016/j.bpg.2018.11.013  0.01
2017 Walker RC, Underwood TJ. Oesophageal cancer Surgery (Oxford). 35: 627-634. DOI: 10.1016/j.mpsur.2017.09.010  0.01
2016 Qureshi YA, Sarker SJ, Walker RC, Hughes SF. Proximal Resection Margin in Ivor-Lewis Oesophagectomy for Cancer. Annals of Surgical Oncology. PMID 27573522 DOI: 10.1245/s10434-016-5510-y  0.01
Hide low-probability matches.